BridgeBio Pharma (BBIO) Other Operating Expenses (2019 - 2026)
BridgeBio Pharma (BBIO) posted Other Operating Expenses of $9.9 million for Q1 2026, up 22.6% sequentially from $8.1 million in Q4 2025, and up 276.62% YoY from $2.6 million in Q1 2025.
BridgeBio Pharma (BBIO) Other Operating Expenses (2019 - 2026) Analysis & Trends
BridgeBio Pharma has reported Other Operating Expenses for 7 years, with the latest figure at $9.9 million in Q1 2026.
- Quarterly Other Operating Expenses rose 276.62% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.3 million (up 337.7% YoY) and the FY2025 annual result came in at $21.0 million, up 440.54% from the prior year.
- Other Operating Expenses rose to $9.9 million in Q1 2026 per BBIO's latest filing, from $8.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $9.9 million in Q1 2026 and troughed at $598000.0 in Q3 2023.
- A 5-year average of $2.6 million and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Other Operating Expenses tumbled 58.28% in 2022, then soared 997.49% in 2025.
- Over 5 years, Other Operating Expenses stood at $647000.0 in 2022, then dropped by 7.57% to $598000.0 in 2023, then soared by 248.49% to $2.1 million in 2024, then jumped by 289.01% to $8.1 million in 2025, then climbed by 22.6% to $9.9 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $9.9 million, $8.1 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.05 Mn |
| Mar 31, 2026 | 9.94 Mn |
| Dec 31, 2025 | 8.11 Mn |
| Sep 30, 2025 | 6.56 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 598,000.00 |
| Sep 30, 2023 | 598,000.00 |
| Jun 30, 2023 | 599,000.00 |
| Mar 31, 2023 | 651,000.00 |
| Dec 31, 2022 | 647,000.00 |
| Sep 30, 2022 | 739,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.45 Mn |